Epigenetics and obesity cardiomyopathy: From pathophysiology to prevention and management

Pharmacology and Therapeutics

Volumn 161, Issue , 2016, Pages 52-66

  Zhang, Yingmei ^a   Ren, Jun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Adipose tissue; Cardiac; Histone modification; Liver; Methylation; Obesity

Indexed keywords

AZACITIDINE; BELINOSTAT; DECITABINE; DNA; ROMIDEPSIN; UNTRANSLATED RNA; VORINOSTAT;

CARDIOMYOPATHY; DISEASE ASSOCIATION; DNA METHYLATION; ENERGY EXPENDITURE; FOOD INTAKE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HEALTH; HEART FUNCTION; HISTONE MODIFICATION; HUMAN; INHERITANCE; NONHUMAN; NUTRITION; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ANIMAL; CARDIOMYOPATHIES; COMPLICATION; DISEASE MANAGEMENT; EPIGENETICS; GENETIC EPIGENESIS; PATHOPHYSIOLOGY;

ANIMALS; CARDIOMYOPATHIES; DISEASE MANAGEMENT; EPIGENESIS, GENETIC; EPIGENOMICS; HUMANS; OBESITY;

EID: 84963529445     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2016.03.005     Document Type: Review

References (187)

1. A. Abbott Project set to map marks on genome Nature 463 2010 596 597
2. O. Ali, D. Cerjak, J.W. Kent Jr., R. James, J. Blangero, M.A. Carless, and Y. Zhang An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome Clin Epigenetics 7 2015 12
3. C. Allard, V. Desgagne, J. Patenaude, M. Lacroix, L. Guillemette, and M.C. Battista M.F. Hivert Mendelian randomization supports causality between maternal hyperglycemia and epigenetic regulation of leptin gene in newborns Epigenetics 10 2015 342 351
4. M.A. Alpert Management of obesity cardiomyopathy Am J Med Sci 321 2001 237 241
5. M.A. Alpert Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome Am J Med Sci 321 2001 225 236
6. M.A. Alpert, C.J. Lavie, H. Agrawal, A. Kumar, and S.A. Kumar Cardiac effects of obesity: pathophysiologic, clinical, and prognostic consequences - a review J Cardiopulm Rehabil Prev 36 2016 1 11
7. American Association for Cancer Research Human Epigenome Task, F., and European Union, N. o. E. S. A. B Moving AHEAD with an international human epigenome project Nature 454 2008 711 715
8. A.O. Arguelles, S. Meruvu, J.D. Bowman, and M. Choudhury Are epigenetic drugs for diabetes and obesity at our door step? Drug Discov Today 21 2016 499 509
9. P. Arner, and A. Kulyte MicroRNA regulatory networks in human adipose tissue and obesity Nat Rev Endocrinol 11 2015 276 288
10. S. Aslibekyan, E.W. Demerath, M. Mendelson, D. Zhi, W. Guan, and L. Liang D.K. Arnett Epigenome-wide study identifies novel methylation loci associated with body mass index and waist circumference Obesity (Silver Spring) 23 2015 1493 1501
11. J. Ayer, M. Charakida, J.E. Deanfield, and D.S. Celermajer Lifetime risk: childhood obesity and cardiovascular risk Eur Heart J 36 2015 1371 1376
12. G.A. Babbitt, E.E. Coppola, M.A. Alawad, and A.O. Hudson Can all heritable biology really be reduced to a single dimension? Gene 578 2016 162 168
13. D.J. Barker Developmental origins of adult health and disease J Epidemiol Community Health 58 2004 114 115
14. D.J. Barker, and K.L. Thornburg The obstetric origins of health for a lifetime Clin Obstet Gynecol 56 2013 511 519
15. S. Barua, and M.A. Junaid Lifestyle, pregnancy and epigenetic effects Epigenomics 7 2015 85 102
16. A. Bhan, and S.S. Mandal Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease ChemMedChem 9 2014 1932 1956
17. D. Bhartiya, S. Jalali, S. Ghosh, and V. Scaria Distinct patterns of genetic variations in potential functional elements in long noncoding RNAs Hum Mutat 35 2014 192 201
18. K. Bhaskaran, I. Douglas, H. Forbes, I. dos-Santos-Silva, D.A. Leon, and L. Smeeth Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults Lancet 384 2014 755 765
19. R.O. Bonow, and R.H. Eckel Diet, obesity, and cardiovascular risk N Engl J Med 348 2003 2057 2058
20. S.S. Boyanapalli, and A.N. Tony Kong "Curcumin, the King of Spices": epigenetic regulatory mechanisms in the prevention of cancer, neurological, and inflammatory diseases Curr Pharmacol Rep 1 2015 129 139
21. A.J. Brazel, and D. Vernimmen The complexity of epigenetic diseases J Pathol 238 2016 333 344
22. T.A. Briggs, K. Lokulo-Sodipe, K.E. Chandler, D.J. Mackay, and I.K. Temple Temple syndrome as a result of isolated hypomethylation of the 14q32 imprinted DLK1/MEG3 region Am J Med Genet A 170 2016 170 175
23. P.K. Bundhun, N. Li, and M.H. Chen Does an obesity paradox really exist after cardiovascular intervention?: a systematic review and meta-analysis of randomized controlled trials and Observational studies Medicine (Baltimore) 94 2015 e1910
24. E. Burgio, A. Lopomo, and L. Migliore Obesity and diabetes: from genetics to epigenetics Mol Biol Rep 42 2015 799 818
25. M. Calore, L.J. De Windt, and A. Rampazzo Genetics meets epigenetics: genetic variants that modulate noncoding RNA in cardiovascular diseases J Mol Cell Cardiol 89 2015 27 34
26. Y. Cao, L. Lu, M. Liu, X.C. Li, R.R. Sun, Y. Zheng, and P.Y. Zhang Impact of epigenetics in the management of cardiovascular disease: a review Eur Rev Med Pharmacol Sci 18 2014 3097 3104
27. B.R. Carone, L. Fauquier, N. Habib, J.M. Shea, C.E. Hart, and R. Li O.J. Rando Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals Cell 143 2010 1084 1096
28. J.E. Castillo-Fernandez, T.D. Spector, and J.T. Bell Epigenetics of discordant monozygotic twins: implications for disease Genome Med 6 2014 60
29. M. Cavalera, J. Wang, and N.G. Frangogiannis Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities Transl Res 164 2014 323 335
30. L. Chang, and J. Neu Early factors leading to later obesity: interactions of the microbiome, epigenome, and nutrition Curr Probl Pediatr Adolesc Health Care 45 2015 134 142
31. A. Chesi, and S.F. Grant The genetics of Pediatric obesity Trends Endocrinol Metab 26 2015 711 721
32. G. Cini, I. Carnevali, M. Quaia, A.M. Chiaravalli, P. Sala, and E. Giacomini A. Viel Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family Carcinogenesis 36 2015 452 458
33. M. Claussnitzer, S.N. Dankel, K.H. Kim, G. Quon, W. Meuleman, and C. Haugen M. Kellis FTO obesity variant circuitry and adipocyte Browning in humans N Engl J Med 373 2015 895 907
34. P. Cordero, J. Li, and J.A. Oben Epigenetics of obesity: beyond the genome sequence Curr Opin Clin Nutr Metab Care 18 2015 361 366
35. K. Dalgaard, K. Landgraf, S. Heyne, A. Lempradl, J. Longinotto, and K. Gossens J.A. Pospisilik Trim28 haploinsufficiency triggers Bi-stable epigenetic obesity Cell 164 2016 353 364
36. M. Daniel, and T.O. Tollefsbol Epigenetic linkage of aging, cancer and nutrition J Exp Biol 218 2015 59 70
37. S.R. Daniels, D.K. Arnett, R.H. Eckel, S.S. Gidding, L.L. Hayman, and S. Kumanyika C.L. Williams Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment Circulation 111 2005 1999 2012
38. S.R. Daniels, M.S. Jacobson, B.W. McCrindle, R.H. Eckel, and B.M. Sanner American Heart Association childhood obesity research Summit: executive summary Circulation 119 2009 2114 2123
39. J.A. Deiuliis MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics Int J Obes 40 2016 88 101
40. C.A. Demetriou, K. van Veldhoven, C. Relton, S. Stringhini, K. Kyriacou, and P. Vineis Biological embedding of early-life exposures and disease risk in humans: a role for DNA methylation Eur J Clin Investig 45 2015 303 332
41. M. Desai, J.K. Jellyman, and M.G. Ross Epigenomics, gestational programming and risk of metabolic syndrome Int J Obes 39 2015 633 641
42. K.J. Dick, C.P. Nelson, L. Tsaprouni, J.K. Sandling, D. Aissi, and S. Wahl N.J. Samani DNA methylation and body-mass index: a genome-wide analysis Lancet 383 2014 1990 1998
43. J. Ding, L.M. Reynolds, T. Zeller, C. Muller, K. Lohman, and B.J. Nicklas Y. Liu Alterations of a cellular cholesterol metabolism network are a molecular feature of obesity-related type 2 diabetes and cardiovascular disease Diabetes 64 2015 3464 3474
44. M. Dong, and J. Ren What fans the fire: insights into mechanisms of leptin in metabolic syndrome-associated heart diseases Curr Pharm Des 20 2014 652 658
45. J. Dooley, J.E. Garcia-Perez, J. Sreenivasan, S.M. Schlenner, R. Vangoitsenhoven, and A.S. Papadopoulou A. Liston The microRNA-29 family dictates the balance between homeostatic and pathological glucose handling in diabetes and obesity Diabetes 65 2016 53 61
46. Q. Du, P.L. Luu, C. Stirzaker, and S.J. Clark Methyl-CpG-binding domain proteins: readers of the epigenome Epigenomics 7 2015 1051 1073
47. O. Dumortier, C. Hinault, and E. Van Obberghen MicroRNAs and metabolism crosstalk in energy homeostasis Cell Metab 18 2013 312 324
48. R.H. Eckel Clinical practice. Nonsurgical management of obesity in adults N Engl J Med 358 2008 1941 1950
49. T. Eggermann, I. Netchine, I.K. Temple, Z. Tumer, D. Monk, and D. Mackay E.R. Maher Congenital imprinting disorders: EUCID.net - a network to decipher their aetiology and to improve the diagnostic and clinical care Clin Epigenetics 7 2015 23
50. T. Eggermann, G. Perez de Nanclares, E.R. Maher, I.K. Temple, Z. Tumer, and D. Monk I. Netchine Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci Clin Epigenetics 7 2015 123
51. A.C. Ehrlich, and F.K. Friedenberg Genetic associations of obesity: the Fat-Mass and obesity-associated (FTO) gene Clin Transl Gastroenterol 7 2016 e140
52. L. Elia, and G. Condorelli RNA (Epi)genetics in cardiovascular diseases J Mol Cell Cardiol 89 2015 11 16
53. B. Feng, P. Jiao, Y. Helou, Y. Li, Q. He, and M.S. Walters H. Xu Mitogen-activated protein kinase phosphatase 3 (MKP-3)-deficient mice are resistant to diet-induced obesity Diabetes 63 2014 2924 2934
54. M.M. Franco, A.R. Prickett, and R.J. Oakey The role of CCCTC-binding factor (CTCF) in genomic imprinting, development, and reproduction Biol Reprod 91 2014 125
55. R.J. Frost, and E.N. Olson Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs Proc Natl Acad Sci U S A 108 2011 21075 21080
56. A.B. Gaikwad, J. Gupta, and K. Tikoo Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions Biochem J 432 2010 333 341
57. T. Gali Ramamoorthy, G. Begum, E. Harno, and A. White Developmental programming of hypothalamic neuronal circuits: impact on energy balance control Front Neurosci 9 2015 126
58. C.M. Ghantous, Z. Azrak, S. Hanache, W. Abou-Kheir, and A. Zeidan Differential role of leptin and adiponectin in cardiovascular system Int J Endocrinol 2015 2015 534320
59. K.M. Godfrey, A. Sheppard, P.D. Gluckman, K.A. Lillycrop, G.C. Burdge, and C. McLean M.A. Hanson Epigenetic gene promoter methylation at birth is associated with child's later adiposity Diabetes 60 2011 1528 1534
60. E. Goodman, L.M. Dolan, J.A. Morrison, and S.R. Daniels Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth Circulation 111 2005 1970 1977
61. C.M. Greco, and G. Condorelli Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure Nat Rev Cardiol 12 2015 488 497
62. C.E. Grueter, E. van Rooij, B.A. Johnson, S.M. DeLeon, L.B. Sutherland, and X. Qi E.N. Olson A cardiac microRNA governs systemic energy homeostasis by regulation of MED13 Cell 149 2012 671 683
63. E.C. Guedes, G.S. Franca, C.A. Lino, F.C. Koyama, L.D. Moreira, and J.G. Alexandre G.P. Diniz MicroRNA expression signature is altered in the cardiac remodeling induced by high fat diets J Cell Physiol 2015 10.1002/jcp.25280 (Epub ahead of print)
64. R. Guo, Y. Zhang, S. Turdi, and J. Ren Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy Biochim Biophys Acta 1832 2013 1136 1148
65. P.P. Gupta, G.C. Fonarow, and T.B. Horwich Obesity and the obesity paradox in heart failure Can J Cardiol 31 2015 195 202
66. J. Haas, K.S. Frese, Y.J. Park, A. Keller, B. Vogel, and A.M. Lindroth B. Meder Alterations in cardiac DNA methylation in human dilated cardiomyopathy EMBO Mol Med 5 2013 413 429
67. P. Haggarty Genetic and metabolic determinants of human epigenetic variation Curr Opin Clin Nutr Metab Care 18 2015 334 338
68. C.A. Hamm, and F.F. Costa Epigenomes as therapeutic targets Pharmacol Ther 151 2015 72 86
69. D.E. Handy, R. Castro, and J. Loscalzo Epigenetic modifications: basic mechanisms and role in cardiovascular disease Circulation 123 2011 2145 2156
70. O.T. Hardy, M.P. Czech, and S. Corvera What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes 19 2012 81 87
71. K. Hogg, and P.S. Western Refurbishing the germline epigenome: out with the old, in with the new Semin Cell Dev Biol 45 2015 104 113
72. S. Horsburgh, P. Robson-Ansley, R. Adams, and C. Smith Exercise and inflammation-related epigenetic modifications: focus on DNA methylation Exerc Immunol Rev 21 2015 26 41
73. S. Horvath, W. Erhart, M. Brosch, O. Ammerpohl, W. von Schonfels, and M. Ahrens J. Hampe Obesity accelerates epigenetic aging of human liver Proc Natl Acad Sci U S A 111 2014 15538 15543
74. Y.J. Hou, C.C. Zhu, X. Duan, H.L. Liu, Q. Wang, and S.C. Sun Both diet and gene mutation induced obesity affect oocyte quality in mice Sci Rep 6 2016 18858
75. A.A. Houde, C. Legare, S. Biron, O. Lescelleur, L. Biertho, and S. Marceau L. Bouchard Leptin and adiponectin DNA methylation levels in adipose tissues and blood cells are associated with BMI, waist girth and LDL-cholesterol levels in severely obese men and women BMC Med Genet 16 2015 29
76. Y. Ji, Z. Wu, Z. Dai, K. Sun, J. Wang, and G. Wu Nutritional epigenetics with a focus on amino acids: implications for the development and treatment of metabolic syndrome J Nutr Biochem 27 2016 1 8
77. X. Jiang, X. Ye, W. Guo, H. Lu, and Z. Gao Inhibition of HDAC3 promotes ligand-independent PPARgamma activation by protein acetylation J Mol Endocrinol 53 2014 191 200
78. J.C. Jimenez-Chillaron, M. Ramon-Krauel, S. Ribo, and R. Diaz Transgenerational epigenetic inheritance of diabetes risk as a consequence of early nutritional imbalances Proc Nutr Soc 75 2016 78 89
79. S.D. Jordan, M. Kruger, D.M. Willmes, N. Redemann, F.T. Wunderlich, and H.S. Bronneke J.C. Bruning Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism Nat Cell Biol 13 2011 434 446
80. P. Kaliman, M.J. Alvarez-Lopez, M. Cosin-Tomas, M.A. Rosenkranz, A. Lutz, and R.J. Davidson Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators Psychoneuroendocrinology 40 2014 96 107
81. Y.H. Kao, G.S. Lien, T.F. Chao, and Y.J. Chen DNA methylation inhibition: a novel therapeutic strategy for heart failure Int J Cardiol 176 2014 232 233
82. E.K. Kasper, R.H. Hruban, and K.L. Baughman Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure Am J Cardiol 70 1992 921 924
83. S.T. Keating, and A. El-Osta Epigenetics and metabolism Circ Res 116 2015 715 736
84. C. Keating, K. Backholer, and A. Peeters Prevalence of overweight and obesity in children and adults Lancet 384 2014 2107 2108
85. S. Kenchaiah, J.C. Evans, D. Levy, P.W. Wilson, E.J. Benjamin, and M.G. Larson R.S. Vasan Obesity and the risk of heart failure N Engl J Med 347 2002 305 313
86. S. Kenchaiah, H.D. Sesso, and J.M. Gaziano Body mass index and vigorous physical activity and the risk of heart failure among men Circulation 119 2009 44 52
87. S.H. Kim, J.P. Despres, and K.K. Koh Obesity and cardiovascular disease: friend or foe? Eur Heart J 2015 (pii: ehv509, Epub ahead of print)
88. D.E. Kok, R.A. Dhonukshe-Rutten, C. Lute, S.G. Heil, A.G. Uitterlinden, and N. van der Velde W.T. Steegenga The effects of long-term daily folic acid and vitamin B12 supplementation on genome-wide DNA methylation in elderly subjects Clin Epigenetics 7 2015 121
89. J.W. Kornfeld, C. Baitzel, A.C. Konner, H.T. Nicholls, M.C. Vogt, and K. Herrmanns J.C. Bruning Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b Nature 494 2013 111 115
90. V. Kotsis, P. Nilsson, G. Grassi, G. Mancia, J. Redon, and F. Luft J. Jordan New developments in the pathogenesis of obesity-induced hypertension J Hypertens 33 2015 1499 1508
91. M. Kundakovic, K. Gudsnuk, J.B. Herbstman, D. Tang, F.P. Perera, and F.A. Champagne DNA methylation of BDNF as a biomarker of early-life adversity Proc Natl Acad Sci U S A 112 2015 6807 6813
92. S. Kurdyukov, and M. Bullock DNA methylation analysis: choosing the right method Biology (Basel) 5 2016
93. C. Kuzmochka, H.S. Abdou, R.J. Hache, and E. Atlas Inactivation of histone deacetylase 1 (HDAC1) but not HDAC2 is required for the glucocorticoid-dependent CCAAT/enhancer-binding protein alpha (C/EBPalpha) expression and preadipocyte differentiation Endocrinology 155 2014 4762 4773
94. B. Labonte, M. Suderman, G. Maussion, L. Navaro, V. Yerko, and I. Mahar G. Turecki Genome-wide epigenetic regulation by early-life trauma Arch Gen Psychiatry 69 2012 722 731
95. R.H. Lane Fetal programming, epigenetics, and adult onset disease Clin Perinatol 41 2014 815 831
96. R. Lardenoije, A. Iatrou, G. Kenis, K. Kompotis, H.W. Steinbusch, and D. Mastroeni B.P. Rutten The epigenetics of aging and neurodegeneration Prog Neurobiol 131 2015 21 64
97. V.J. Lavallard, A.J. Meijer, P. Codogno, and P. Gual Autophagy, signaling and obesity Pharmacol Res 66 2012 513 525
98. C.J. Lavie, P.A. McAuley, T.S. Church, R.V. Milani, and S.N. Blair Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox J Am Coll Cardiol 63 2014 1345 1354
99. C.J. Lavie, A. Sharma, M.A. Alpert, A. De Schutter, F. Lopez-Jimenez, R.V. Milani, and H.O. Ventura Update on obesity and obesity paradox in heart failure Prog Cardiovasc Dis 58 2016 393 400
100. H.S. Lee Impact of maternal diet on the epigenome during In utero life and the developmental programming of diseases in childhood and adulthood Nutrients 7 2015 9492 9507
101. S.L. Lewandowski, H.P. Janardhan, K.M. Smee, M. Bachman, Z. Sun, M.A. Lazar, and C.M. Trivedi Histone deacetylase 3 modulates Tbx5 activity to regulate early cardiogenesis Hum Mol Genet 23 2014 3801 3809
102. L. Li, Y. Hua, M. Dong, Q. Li, D.T. Smith, and M. Yuan J. Ren Short-term lenalidomide (Revlimid) administration ameliorates cardiomyocyte contractile dysfunction in ob/ob obese mice Obesity (Silver Spring) 20 2012 2174 2185
103. L. Liang, X.L. Shou, H.K. Zhao, G.Q. Ren, J.B. Wang, and X.H. Wang Y. Zhang Antioxidant catalase rescues against high fat diet-induced cardiac dysfunction via an IKKbeta-AMPK-dependent regulation of autophagy Biochim Biophys Acta 1852 2015 343 352
104. W.Y. Lim, Y.S. Lee, F.K. Yap, I.M. Aris, L. Ngee, and M. Meaney A. Pan Maternal blood pressure during pregnancy and early childhood blood pressures in the offspring: the GUSTO birth cohort study Medicine (Baltimore) 94 2015 e1981
105. M. Lombo, C. Fernandez-Diez, S. Gonzalez-Rojo, C. Navarro, V. Robles, and M.P. Herraez Transgenerational inheritance of heart disorders caused by paternal bisphenol A exposure Environ Pollut 206 2015 667 678
106. R.H. Mackey, K.M. McTigue, Y.F. Chang, E. Barinas-Mitchell, R.W. Evans, and L.F. Tinker L.H. Kuller Lipoprotein particles and size, total and high molecular weight adiponectin, and leptin in relation to incident coronary heart disease among severely obese postmenopausal women: the Women's Health Initiative Observational study BBA Clin 3 2015 243 250
107. R. Mahajan, D.H. Lau, and P. Sanders Impact of obesity on cardiac metabolism, fibrosis, and function Trends Cardiovasc Med 25 2015 119 126
108. M.L. Mansego, F.I. Milagro, M.A. Zulet, and J.A. Martinez SH2B1 CpG-SNP is associated with body weight reduction in obese subjects following a dietary restriction program Ann Nutr Metab 66 2015 1 9
109. J. Marin-Garcia, and A.T. Akhmedov Epigenetics of the failing heart Heart Fail Rev 20 2015 435 459
110. J.L. Marques-Rocha, M. Samblas, F.I. Milagro, J. Bressan, J.A. Martinez, and A. Marti Noncoding RNAs, cytokines, and inflammation-related diseases FASEB J 29 2015 3595 3611
111. C.P. Martinez-Jimenez, and J. Sandoval Epigenetic crosstalk: a molecular language in human metabolic disorders Front Biosci (Schol Ed) 7 2015 46 57
112. P. Maurovich-Horvat, K. Kallianos, L.C. Engel, J. Szymonifka, C.L. Schlett, and W. Koenig Q.A. Truong Relationship of thoracic fat depots with coronary atherosclerosis and circulating inflammatory biomarkers Obesity (Silver Spring) 23 2015 1178 1184
113. H.M. Medford, E.J. Cox, L.E. Miller, and S.A. Marsh Consuming a Western diet for two weeks suppresses fetal genes in mouse hearts Am J Physiol Regul Integr Comp Physiol 306 2014 R519 R526
114. D.M. Messerschmidt, B.B. Knowles, and D. Solter DNA methylation dynamics during epigenetic reprogramming in the germline and preimplantation embryos Genes Dev 28 2014 812 828
115. K.M. Meurs, and M. Kuan Differential methylation of CpG sites in two isoforms of myosin binding protein C, an important hypertrophic cardiomyopathy gene Environ Mol Mutagen 52 2010 161 164
116. F.I. Milagro, P. Gomez-Abellan, J. Campion, J.A. Martinez, J.M. Ordovas, and M. Garaulet CLOCK, PER2 and BMAL1 DNA methylation: association with obesity and metabolic syndrome characteristics and monounsaturated fat intake Chronobiol Int 29 2012 1180 1194
117. R.L. Montgomery, C.A. Davis, M.J. Potthoff, M. Haberland, J. Fielitz, X. Qi, J.A. Hill, J.A. Richardson, and E.N. Olson Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility Genes Dev 21 2007 1790 1802
118. C.S. Morgen, and T.I. Sorensen Obesity: global trends in the prevalence of overweight and obesity Nat Rev Endocrinol 10 2014 513 514
119. A.K. Murashov, E.S. Pak, M. Koury, A. Ajmera, M. Jeyakumar, and M. Parker P.D. Neufer Paternal long-term exercise programs offspring for low energy expenditure and increased risk for obesity in mice FASEB J 30 2016 775 784
120. R. Mysore, Y. Zhou, S. Sadevirta, H. Savolainen-Peltonen, P.A. Nidhina Haridas, and J. Soronen V.M. Olkkonen MicroRNA-192∗impairs adipocyte triglyceride storage Biochim Biophys Acta 1864 2016 324 351
121. K.J. Nadeau, D.M. Maahs, S.R. Daniels, and R.H. Eckel Childhood obesity and cardiovascular disease: links and prevention strategies Nat Rev Cardiol 8 2011 513 525
122. R.P. Nair, and J. Ren Pharmacotherapy of obesity - benefit, bias and hyperbole Curr Med Chem 16 2009 1888 1897
123. C.J. Nalliah, P. Sanders, H. Kottkamp, and J.M. Kalman The role of obesity in atrial fibrillation Eur Heart J 2015 (pii: ehv486)
124. P.D. Neufer, M.M. Bamman, D.M. Muoio, C. Bouchard, D.M. Cooper, and B.H. Goodpaster M.R. Laughlin Understanding the cellular and molecular mechanisms of physical activity-induced health benefits Cell Metab 22 2015 4 11
125. M. Ng, T. Fleming, M. Robinson, B. Thomson, N. Graetz, and C. Margono E. Gakidou Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013 Lancet 384 2014 766 781
126. E. Nilsson, A. Matte, A. Perfilyev, V.D. de Mello, P. Kakela, J. Pihlajamaki, and C. Ling Epigenetic alterations in human liver from subjects with type 2 diabetes in Parallel with reduced folate levels J Clin Endocrinol Metab 100 2015 E1491 E1501
127. M. Ollikainen, K. Ismail, K. Gervin, A. Kyllonen, A. Hakkarainen, and J. Lundbom J. Kaprio Genome-wide blood DNA methylation alterations at regulatory elements and heterochromatic regions in monozygotic twins discordant for obesity and liver fat Clin Epigenetics 7 2015 39
128. J. Osorio Obesity. Looking at the epigenetic link between obesity and its consequences - the promise of EWAS Nat Rev Endocrinol 10 2014 249
129. A. Ost, A. Lempradl, E. Casas, M. Weigert, T. Tiko, and M. Deniz J.A. Pospisilik Paternal diet defines offspring chromatin state and intergenerational obesity Cell 159 2014 1352 1364
130. S. Ounzain, and T. Pedrazzini Super-enhancer lncs to cardiovascular development and disease Biochim Biophys Acta 2015 (pii: S0167-4889(15)00410-3)
131. T. Owan, and S.E. Litwin Is there a cardiomyopathy of obesity? Curr Heart Fail Rep 4 2007 221 228
132. S.E. Ozanne Epigenetics and metabolism in 2014: metabolic programming-knowns, unknowns and possibilities Nat Rev Endocrinol 11 2015 67 68
133. H. Pan, X. Lin, Y. Wu, L. Chen, A.L. Teh, and S.E. Soh J.D. Holbrook HIF3A association with adiposity: the story begins before birth Epigenomics 7 2015 937 950
134. J. Pasquier, J. Hoarau-Vechot, K. Fakhro, A. Rafii, and C. Abi Khalil Epigenetics and cardiovascular disease in diabetes Curr Diab Rep 15 2015 108
135. B. Paul, S. Barnes, W. Demark-Wahnefried, C. Morrow, C. Salvador, C. Skibola, and T.O. Tollefsbol Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases Clin Epigenetics 7 2015 112
136. P. Poirier, T.D. Giles, G.A. Bray, Y. Hong, J.S. Stern, F.X. Pi-Sunyer, and R.H. Eckel Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss Arterioscler Thromb Vasc Biol 26 2006 968 976
137. A. Portela, and M. Esteller Epigenetic modifications and human disease Nat Biotechnol 28 2010 1057 1068
138. J. Pozzo, P. Fournier, O. Lairez, P.L. Vervueren, C. Delmas, and M. Elbaz J. Roncalli Obesity paradox: origin and best way to assess severity in patients with systolic HF Obesity (Silver Spring) 23 2015 2002 2008
139. S. Ramachandran, J. Ient, E.L. Gottgens, A.J. Krieg, and E.M. Hammond Epigenetic therapy for Solid Tumors: Highlighting the impact of tumor hypoxia Genes (Basel) 6 2015 935 956
140. M. Rask-Andersen, M.S. Almen, and H.B. Schioth Scrutinizing the FTO locus: compelling evidence for a complex, long-range regulatory context Hum Genet 134 2015 1183 1193
141. M.A. Reddy, and R. Natarajan Recent developments in epigenetics of acute and chronic kidney diseases Kidney Int 88 2015 250 261
142. J. Ren, and P. Anversa The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome Biochem Pharmacol 93 2015 409 417
143. J. Ren, and R.O. Kelley Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology Obesity (Silver Spring) 17 2009 1114 1123
144. J. Ren, and Y. Zhang Emerging potential of therapeutic targeting of autophagy and protein quality control in the management of cardiometabolic diseases Biochim Biophys Acta 1852 2015 185 187
145. A.M. Ribeiro, C. Lima Mde, P.I. de Lira, and G.A. da Silva Low birth weight and obesity: causal or casual association? Rev Paul Pediatr 33 2015 341 349
146. G. Rizki, and L.A. Boyer Lncing epigenetic control of transcription to cardiovascular development and disease Circ Res 117 2015 192 206
147. T. Ronn, P. Volkov, L. Gillberg, M. Kokosar, A. Perfilyev, and A.L. Jacobsen C. Ling Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood Hum Mol Genet 24 2015 3792 3813
148. V. Rottiers, and A.M. Naar MicroRNAs in metabolism and metabolic disorders Nat Rev Mol Cell Biol 13 2012 239 250
149. J. Sargent Obesity: obesity turns the hepatic epigenetic clock forward Nat Rev Endocrinol 11 2015 2
150. C. Schiano, M.T. Vietri, V. Grimaldi, A. Picascia, M.R. Pascale, and C. Napoli Epigenetic-related therapeutic challenges in cardiovascular disease Trends Pharmacol Sci 36 2015 226 235
151. D.E. Schones, A. Leung, and R. Natarajan Chromatin modifications associated with diabetes and obesity Arterioscler Thromb Vasc Biol 35 2015 1557 1561
152. A. Sharma, C.J. Lavie, J.S. Borer, A. Vallakati, S. Goel, and F. Lopez-Jimenez J.M. Lazar Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure Am J Cardiol 115 2015 1428 1434
153. W. Shen, C. Wang, L. Xia, C. Fan, H. Dong, R.J. Deckelbaum, and K. Qi Epigenetic modification of the leptin promoter in diet-induced obese mice and the effects of N - 3 polyunsaturated fatty acids Sci Rep 4 2014 5282
154. M. Simmonds, J. Burch, A. Llewellyn, C. Griffiths, H. Yang, and C. Owen N. Woolacott The use of measures of obesity in childhood for predicting obesity and the development of obesity-related diseases in adulthood: a systematic review and meta-analysis Health Technol Assess 19 2015 1 336
155. N.K. Singhal, S. Li, E. Arning, K. Alkhayer, R. Clements, and Z. Sarcyk J. McDonough Changes in methionine metabolism and histone H3 trimethylation are linked to mitochondrial defects in multiple sclerosis J Neurosci 35 2015 15170 15186
156. S. Sivanandam, A.R. Sinaiko, D.R. Jacobs Jr., L. Steffen, A. Moran, and J. Steinberger Relation of increase in adiposity to increase in left ventricular mass from childhood to young adulthood Am J Cardiol 98 2006 411 415
157. J.M. Slack Conrad Hal Waddington: the last Renaissance biologist? Nat Rev Genet 3 2002 889 895
158. A. Soubry Epigenetic inheritance and evolution: a paternal perspective on dietary influences Prog Biophys Mol Biol 118 2015 79 85
159. L.S. Sperling, J.I. Mechanick, I.J. Neeland, C.J. Herrick, J.P. Despres, and C.E. Ndumele S.M. Grundy The CardioMetabolic health alliance: working toward a new care model for the metabolic syndrome J Am Coll Cardiol 66 2015 1050 1067
160. R. Stegemann, and D.A. Buchner Transgenerational inheritance of metabolic disease Semin Cell Dev Biol 43 2015 131 140
161. A. Stokes, and S.H. Preston Smoking and reverse causation create an obesity paradox in cardiovascular disease Obesity (Silver Spring) 2015
162. K. Takahashi, T. Sasano, K. Sugiyama, J. Kurokawa, N. Tamura, and Y. Soejima T. Furukawa High-fat diet increases vulnerability to atrial arrhythmia by conduction disturbance via miR-27b J Mol Cell Cardiol 90 2016 38 46
163. J.G. Thome, M.R. Mendoza, A.V. Cheuiche, V.L. La Porta, D. Silvello, and K.G. Dos Santos A. Biolo Circulating microRNAs in obese and lean heart failure patients: A case-control study with computational target prediction analysis Gene 574 2015 1 10
164. K.L. Thornburg The programming of cardiovascular disease J Dev Orig Health Dis 6 2015 366 376
165. M. Trajkovski, J. Hausser, J. Soutschek, B. Bhat, A. Akin, and M. Zavolan M. Stoffel MicroRNAs 103 and 107 regulate insulin sensitivity Nature 474 2011 649 653
166. M. Trerotola, V. Relli, P. Simeone, and S. Alberti Epigenetic inheritance and the missing heritability Hum Genomics 9 2015 17
167. S. Turdi, W. Sun, Y. Tan, X. Yang, L. Cai, and J. Ren Inhibition of DNA methylation attenuates low-dose cadmium-induced cardiac contractile and intracellular Ca(2 +) anomalies Clin Exp Pharmacol Physiol 40 2013 706 712
168. S. Udali, P. Guarini, S. Moruzzi, S.W. Choi, and S. Friso Cardiovascular epigenetics: from DNA methylation to microRNAs Mol Asp Med 34 2013 883 901
169. M. Ungerer, J. Knezovich, and M. Ramsay In utero alcohol exposure, epigenetic changes, and their consequences Alcohol Res 35 2013 37 46
170. A. Vaiserman Epidemiologic evidence for association between adverse environmental exposures in early life and epigenetic variation: a potential link to disease susceptibility? Clin Epigenetics 7 2015 96
171. A.M. Vaiserman Early-life exposure to substance abuse and risk of type 2 diabetes in adulthood Curr Diab Rep 15 2015 624
172. S.J. van Dijk, P.L. Molloy, H. Varinli, J.L. Morrison, and B.S. Muhlhausler Epigenetics and human obesity Int J Obes 39 2015 85 97
173. L.F. Van Gaal, and A.P. Maggioni Overweight, obesity, and outcomes: fat mass and beyond Lancet 383 2014 935 936
174. S. Voelter-Mahlknecht Epigenetic associations in relation to cardiovascular prevention and therapeutics Clin Epigenetics 8 2016 4
175. M.L. Wahlqvist, S.A. Krawetz, N.S. Rizzo, M.G. Dominguez-Bello, L.M. Szymanski, and S. Barkin J.G. Kral Early-life influences on obesity: from preconception to adolescence Ann N Y Acad Sci 1347 2015 1 28
176. J. Wang, Z. Wu, D. Li, N. Li, S.V. Dindot, and M.C. Satterfield G. Wu Nutrition, epigenetics, and metabolic syndrome Antioxid Redox Signal 17 2012 282 301
177. A.L. Webster, M.S. Yan, and P.A. Marsden Epigenetics and cardiovascular disease Can J Cardiol 29 2013 46 57
178. S. Wharton Current perspectives on long-term pharmacotherapy for obesity Can J Diabetes 2015 10.1016/j.jcjd.2015.07.005 (pii: S1499-2671(15)00553-5)
179. T.F. Whayne Epigenetics in the development, modification, and prevention of cardiovascular disease Mol Biol Rep 42 2015 765 776
180. S. Xu, P. Chen, and L. Sun Regulatory networks of non-coding RNAs in brown/beige adipogenesis Biosci Rep 35 2015
181. M.S. Yan, and P.A. Marsden Epigenetics in the vascular endothelium: looking from a different perspective in the epigenomics era Arterioscler Thromb Vasc Biol 35 2015 2297 2306
182. S. Yara, J.C. Lavoie, and E. Levy Oxidative stress and DNA methylation regulation in the metabolic syndrome Epigenomics 7 2015 283 300
183. Y. Zhang, and J. Ren Role of cardiac steatosis and lipotoxicity in obesity cardiomyopathy Hypertension 57 2011 148 150
184. Y. Zhang, and J. Ren Targeting autophagy for the therapeutic application of histone deacetylase inhibitors in ischemia/reperfusion heart injury Circulation 129 2014 1088 1091
185. Y. Zhang, J.W. Kent II, A. Lee, D. Cerjak, O. Ali, and R. Diasio A.H. Kissebah Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a Northern European family population BMC Med Genet 6 2013 9
186. Y. Zhang, X. Xu, and J. Ren MTOR overactivation and interrupted autophagy flux in obese hearts: a dicey assembly? Autophagy 9 2013 939 941
187. Y. Zhang, M. Yuan, K.M. Bradley, F. Dong, P. Anversa, and J. Ren Insulin-like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: role of insulin signaling and mitochondrial function Hypertension 59 2012 680 693